Morningstar: 15% Recovery With Room To Climb Higher

Impact · against what's priced in

Morningstar shows strong fundamental momentum with significant margin expansion and double-digit EPS growth. The combination of a reaffirmed buy rating and a 33% discount to fair value suggests a positive catalyst for price appreciation.

MORN+0.60

No priced-in read yet

In context

Q2 2026 results delivered a 280-basis-point margin expansion and 29.2% EPS growth, while consensus projects 16.7% annual EPS growth through 2028.

Read from the article alone

• earnings▲<1%
• revenue growth
• dividends
• valuation
• eps
• MORN
• acquisitions
• financial services
• margins